Search PubMed⌕ Search

Biomedical subjects

D Wilkinson

Publications and source records attributed to D Wilkinson.

At least 217 records · Page 12Linked to original sources

Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.

A panel of primary syncytium-inducing (SI) human immunodeficiency virus type 1 isolates that infected several CD4+ T-cell lines, including MT-2 and C8166, were tested for infection of blood-derived macrophages. Infectivity titers for C8166 cells and macrophages demonstrated that primary SI strains infected macrophages much more efficiently than T-cell line-adapted HIV-1 strains such as LAI and RF. These primary SI strains were therefore dual-tropic. Nine biological clones of two SI strains, prepared by limiting dilution, had macrophage/C8166 infectivity ratios similar to those of their parental viruses, indicating that the dual-tropic phenotype was not due to a mixture of non-SI/macrophage-tropic and SI/T-cell tropic viruses. We tested whether the primary SI strains used either Lestr (fusin) or CCR5 as coreceptors. Infection of cat CCC/CD4 cells transiently expressing Lestr supported infection by T-cell line-adapted strains including LAI, whereas CCC/CD4 cells expressing CCR5 were sensitive to primary non-SI strains as well as to the molecularly cloned strains SF-162 and JR-CSF. Several primary SI strains, as well as the molecularly cloned dual-tropic viruses 89.6 and GUN-1, infected both Lestr+ and CCR5+ CCC/CD4 cells. Thus, these viruses can choose between Lestr and CCR5 for entry into cells. Interestingly, some dual-tropic primary SI strains that infected Lestr+ cells failed to infect CCR5+ cells, suggesting that these viruses may use an alternative coreceptor for infection of macrophages. Alternatively, CCR5 may be processed or presented differently on cat cells so that entry of some primary SI strains but not others is affected.

CD4-Positive T-Lymphocytes↗

Directly observed therapy for tuberculosis in rural South Africa, 1991 through 1994.

OBJECTIVES: This paper describes an audit of a community-based tuberculosis treatment program involving directly observed therapy in South Africa. METHODS: A program audit of 2473 consecutive tuberculosis patients in Hlabisa Health District, KwaZulu/Natal, South Africa, was conducted between 1991 and 1994. RESULTS: Monthly admissions increased from 34 per month in 1991 to 66 in 1994. Of 2186 patients managed in Hlabisa, 1903 (87%) received directly observed therapy. Of those receiving directly observed therapy, 1034 (55%) were supervised by volunteers; 743 (72%) of these were supervised by storekeepers. Among those patients managed locally, 1679 (85%) of 1967 surviving patients completed treatment. Completion rates for patients supervised by health workers and non-health workers were the same. Completion fell from a high of 90% in 1992 to 78% in 1994. Mortality increased from 5% in 1991 to 10% in 1994. CONCLUSIONS: Community-based directly observed therapy that uses an intermittent drug regime and volunteers as supervisors can achieve high treatment completion rates for tuberculosis, even in resource-poor settings.

Adult↗

HIV-related tuberculosis in South Africa--clinical features and outcome.

OBJECTIVE: To assess the difference between human immunodeficiency virus (HIV)-infected and non-infected tuberculosis patients with regard to demographic characteristics, clinical features, case fatality rates and, particularly, compliance with therapy. DESIGN: Cohort study. SETTING: Hlabisa Hospital, KwaZulu-Natal, a 450-bed hospital serving a rural district containing 180,000 people. PATIENTS: Two hundred and ninety-seven consecutive adult patients ( > 15 years) diagnosed with tuberculosis. MAIN OUTCOME MEASURES: Age, sex, type of tuberculosis, case fatality rate and compliance with therapy. RESULTS: A total of 107 out of 297 (36%) adults tested HIV-positive (95% confidence interval (CI) 31-42%). Prevalence of HIV infection was higher in women than men (46% v. 29%, relative risk (RR) 1.6, 95% CI 1.2-2.2). HIV-positive patients were significantly younger than HIV-negative patients (mean age 31.2 years v. 38.7 years; P < 0.001). Extrapulmonary tuberculosis (EPTB) was more common in HIV-positive patients (41% v. 11%, RR 3.7, 95% CI 2.3-5.9). The case fatality rate was higher in HIV-positive patients (13% v. 9%, RR 1.5, 95% CI 0.7-3.0). Many more HIV-positive patients failed to complete treatment (21% v. 7%, RR 3.0, 95% CI 1.5-6.0). CONCLUSIONS: We found that HIV-positive patients with tuberculosis were three times more likely to fail to complete treatment than HIV-negative patients. HIV infection is clearly altering the epidemiological profile of tuberculosis in rural South Africa and poses an additional challenge to tuberculosis control programmes to maintain high case-holding rates among HIV-infected tuberculosis patients.

AIDS-Related Opportunistic Infections↗

HIV and tuberculosis.

Explore the source record for details and available documents.

AIDS-Related Opportunistic Infections↗

On the other side.

Explore the source record for details and available documents.

Coronary Artery Bypass↗

Migration and AIDS.

Explore the source record for details and available documents.

Acquired Immunodeficiency Syndrome↗

Characterisation of the Sek-1 receptor tyrosine kinase.

We present an initial characterisation of the mouse Sek-1 protein, a member of the Eph subfamily of putative receptor tyrosine kinases, which has been proposed to play a role in the segmentation of both the hindbrain and the mesoderm. Antibodies raised against the protein have been used to confirm the early embryonic expression pattern previously established by mRNA in situ hybridisation. These antibodies, together with the expression of the Sek-1 gene in a baculovirus system, were instrumental in demonstrating that the protein carries a tyrosine kinase activity and that it is presented at the cell surface with its N-terminal (putative ligand-binding) domain outside of the cell. Therefore, as expected from its amino acid sequence, Sek-1 conforms to the general model of receptor-type tyrosine kinases.

Animals↗

Automated high-performance liquid chromatographic method for the determination of nedocromil sodium in human urine using bimodal column switching.

An automated HPLC method is described for the determination of nedocromil sodium in human urine. An HPLC autosampler is used to inject urine samples onto a short reversed-phase column. This column acts as a concentration column and performs a preliminary extraction. The concentration column is automatically back-flushed onto an ion-exchange column where final separation of nedocromil sodium from urine constituents occurs. Recovery, accuracy, precision, sensitivity and specificity were investigated. The method has been applied to urine samples from clinical studies, and the results were compared to those obtained using a radioimmunoassay developed previously.

Chromatography, High Pressure Liquid↗

Determination of dopexamine hydrochloride in human blood by high-performance liquid chromatography with electrochemical detection.

A method is described for the determination of dopexamine hydrochloride at concentrations of 5 to 100 ng/ml in human blood using electrochemical detection. The method uses a Hypersil ODS column and a mobile phase containing heptane sulphonate, orthophosphoric acid, diisopropylamine and disodium EDTA. Blood samples are stabilised immediately after collection by the use of dipotassium EDTA and a high concentration of sodium metabisulphite. The sample preparation procedure consists of a simple de-proteinisation with perchloric acid. The method is accurate, with inter-assay accuracies ranging from 100 to 104%, and is free of interference by blood from different individuals. Known and potential metabolites of dopexamine hydrochloride and a wide range of drugs do not interfere with the method. The method is precise with inter-assay coefficients of variation of 10.6% at 5 ng/ml and of less than 4.2% at higher concentrations. Stabilised blood samples may be stored for over six months at -25 degrees C prior to analysis.

Adrenergic beta-Agonists↗

Use of thiacetazone.

Explore the source record for details and available documents.

AIDS-Related Opportunistic Infections↗

Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro.

A model system was developed to allow investigation of the frequency at which clastogenic and/or mutagenic events occur in situ in a transplantable murine fibrosarcoma tumour (MC1A-C1) compared with in vitro culture. The marker selected for detecting these events was the X-linked hprt (hypoxanthine-guanine phosphoribosyltransferase) gene. We found that the hprt gene in MC1A-C1 was not suitable for this purpose, most likely because multiple active copies were present. To circumvent the problem, HPRT- [6-thioguanine (6-TG)-resistant] clones were isolated by inactivating all hprt genes with methylnitrosourea. Spontaneous revertants to hypoxanthine/aminopterin/thymidine resistance (HATR) were isolated and found to be approximately 1000 times more sensitive than the parental tumour to induction of 6-TGR mutants by cobalt-60 gamma-rays. This sensitivity is expected for a heterozygous marker, these revertants may therefore possess only one functional hprt locus but two or more active X chromosomes. A clone with a stable hprt gene was identified and a neo gene was introduced. The resulting cell line (MN-11) could be grown as a subcutaneous tumour in syngeneic C57BL/6 animals. The frequency of mutations arising in vivo in the marker hprt gene could be estimated by culturing explanted tumour cells in the presence of 6-TG, using G418 selection to distinguish tumour from host cells. The frequency of mutants in MN-11 cells grown as tumours was found to be 3.4-fold higher than in tissue culture for an equivalent period of time. These data provide the first direct evidence for the existence of mutagenic factors in a tumour environment that might contribute to tumour progression.

Animals↗